New research shows women in the perimenopausal transition face significantly higher cardiovascular risks than previously understood, making midlife a critical moment to act on heart health before it is too late.
Perimenopause, the transitional phase that typically begins in a woman’s late 30s to early 40s, is emerging as a critical and largely overlooked window for cardiovascular health. Cardiovascular disease is the leading cause of death among women worldwide, responsible for roughly 30% of all female fatalities according to the World Heart Federation, and new research suggests the risks begin accumulating far earlier than most clinical conversations acknowledge. Most discussions about women and heart disease tend to focus on the postmenopausal years, when estrogen levels have already dropped and the damage is often well underway. A growing body of research is now making the case that this framing arrives too late, and that the real window for intervention opens years earlier, during the perimenopausal transition.
What the research found
A study published in the Journal of the American Heart Association examined health data from more than 9,200 women between the ages of 18 and 80 who participated in the National Health and Nutrition Examination Survey between 2007 and 2020. Researchers categorized participants into premenopausal, perimenopausal, and postmenopausal groups and measured each group against the American Heart Association’s Life’s Essential 8, a framework covering key health indicators including diet, physical activity, blood pressure, blood sugar, cholesterol, sleep, smoking status, and body weight.
The findings were striking. Perimenopause in women scored significantly lower across those metrics than their premenopausal counterparts, with diet emerging as the area of sharpest decline. Women in the perimenopause group were twice as likely to have a low cardiovascular health score compared to women who had not yet begun the transition.
The lead researcher on the study noted that perimenopause has historically been treated as a waiting room for the postmenopausal stage rather than a distinct and high-stakes period for cardiovascular health in its own right. That framing, the research suggests, is a significant oversight.
Why perimenopause changes the equation
Perimenopause typically begins in a woman’s late 30s to early 40s and can last for several years before menopause arrives. During that stretch, hormonal fluctuations are continuous and their effects on the body are far-reaching. Cardiologists point to adverse changes in lipid profiles and increased insulin resistance as two of the more significant metabolic shifts that accompany the hormonal changes of this period. Both factors contribute directly to elevated cardiovascular risk.
The problem is that these changes often occur gradually and without obvious symptoms, making it easy for women and their physicians to underestimate what is happening at the metabolic level. By the time postmenopause arrives and cardiovascular risk becomes a more prominent part of clinical conversations, years of compounding risk may already have accumulated.
The role of diet during the transition
Among all the factors examined in the study, diet showed the most pronounced gap between perimenopause and premenopause in women. Nutrition specialists working in this space emphasize that the dietary approach during perimenopause should shift away from restriction and toward strategic nourishment.
The specific nutritional priorities that researchers and clinicians highlight for this life stage include adequate hydration and electrolyte balance, calcium and vitamin D intake for bone health, colorful fruits and vegetables rich in polyphenols and antioxidants, fermented foods like yogurt and kimchi for gut health, omega-3 fatty acids from sources such as salmon and walnuts to support cardiovascular function, prebiotic fibers from beans and oats, and consistent protein intake to preserve muscle mass and support metabolic health.
Each of these priorities maps onto a specific biological need that intensifies during perimenopause. Omega-3s help manage inflammation and support healthy cholesterol levels. Polyphenol-rich produce supports vascular function. Protein becomes increasingly important as muscle mass naturally declines with age, a shift that has downstream effects on metabolism and insulin sensitivity.
Shifting the conversation earlier
The broader implication of this research is that cardiovascular risk assessment for women should not wait until after menopause. Clinicians and researchers in this field are increasingly calling for routine discussions about heart health to begin during the perimenopausal transition, when lifestyle interventions still have significant protective potential.
That means primary care physicians, gynecologists, and cardiologists need to be speaking the same language when it comes to women in their late 30s and 40s presenting with early perimenopausal symptoms. Hormonal changes do not stay in one lane. They affect the heart, the metabolism, bone density, and mental health simultaneously, and a siloed approach to any one of those concerns misses the full picture.
For women navigating this transition, the research offers both a warning and a clear opportunity. The perimenopausal years are not a period of inevitable decline. They are a defined window during which informed choices about nutrition, physical activity, and preventive care can meaningfully shape cardiovascular health for decades to come.
